Transcriptomic profiling of LoVo colorectal cancer cells treated with the intestinal absorption solution of Quxie Capsule
This study investigated the transcriptional response of human colorectal cancer LoVo cells to the intestinal absorption solution of Quxie Capsule (QX-IAS). LoVo cells were treated with QX-IAS or blank intestinal absorption solution (Control-IAS) for 48 h, with three independent biological replicates per group. RNA sequencing was performed to identify QX-responsive genes and molecular pathways potentially involved in the anti-colorectal cancer effects of QX.